Summers Value Fund adds TBPH, exits ADMA among Q1 moves
Source: SeekingAlpha
2026-04-29 11:26:39 ET
More on Theravance Biopharma
- Theravance Biopharma: A Special Situation With A 50-100% Likely Upside
- Theravance drops rare disease drug after late-stage trial setback
- Seeking Alpha’s Quant Rating on Theravance Biopharma
- Historical earnings data for Theravance Biopharma
- Financial information for Theravance Biopharma
Read the full article on Seeking Alpha
For further details see:
Summers Value Fund adds TBPH, exits ADMA among Q1 moves
Avanos Medical Inc.
NASDAQ: AVNS
AVNS Trading
0.0% G/L:
$24.98 Last:
196,105 Volume:
$24.99 Open:
AVNS Latest News
$683,750,500
45,954,718
0.18%
112
N/A
Medical Equipment & Supplies
Healthcare
US
Alpharetta
